Literature DB >> 9284098

Decreased level of prosaposin in atopic skin.

C Y Cui1, S Kusuda, T Seguchi, M Takahashi, K Aisu, T Tezuka.   

Abstract

In the skin of atopic dermatitis patients, the amount of ceramides in the stratum corneum is decreased. Although the cause of this decrease may be due to the higher activity of acylase, a decrease in the activity of sphingolipid activator proteins may also be the cause. A polyclonal antibody to saposin D, elicited by immunizing rabbits with the synthetic polypeptide from cDNA of saposin D, cross-reacted with a single 65-kDa epidermal protein of pI 5.6 in a 2-dimensional immunoblot study, suggesting that it was prosaposin, the precursor protein of saposin D, from its molecular weight and demonstrating its immunohistochemical localization in the innermost cell layers of the stratum corneum of the skin. The antigenic material was also observed in the epithelium of the esophagus, pneumocytes of the lungs, hepatocytes, and glandular cells of the stomach. Immunoelectron microscopy showed the antigenic material in the cytoplasm of the granular cells and the intercellular spaces, either between the stratum granulosum and the stratum corneum or on the stratum corneum cell envelope. By ELISA, the amount of the 65-kDa protein in the inner surface skin of the upper arm of atopic dermatitis patients (nonlesional skin) [4.1 +/- 2.0 microg per 7 mm2 (mean +/- SD), n = 10] was found to be significantly decreased (p < 0.05) to 66% of that in the normal control (6.2 +/- 1.5 microg per 7 mm2, n = 10). Therefore, the suppression of prosaposin synthesis may be related to the abnormal stratum corneum formation in atopic skin through lower activation of glucosylcerebrosidase or sphingomyelinase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284098     DOI: 10.1111/1523-1747.ep12335839

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-06

2.  Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators.

Authors:  Yutaka Hatano; Mao-Qiang Man; Yoshikazu Uchida; Debra Crumrine; Theodora M Mauro; Kenneth R Feingold; Peter M Elias; Walter M Holleran
Journal:  J Allergy Clin Immunol       Date:  2009-10-08       Impact factor: 10.793

3.  Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin.

Authors:  Jacquelyn Levin; Sheila Fallon Friedlander; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-11

Review 4.  The role of epidermal sphingolipids in dermatologic diseases.

Authors:  Sonia Borodzicz; Lidia Rudnicka; Dagmara Mirowska-Guzel; Agnieszka Cudnoch-Jedrzejewska
Journal:  Lipids Health Dis       Date:  2016-01-19       Impact factor: 3.876

5.  Permeability Barrier and Microstructure of Skin Lipid Membrane Models of Impaired Glucosylceramide Processing.

Authors:  Michaela Sochorová; Klára Staňková; Petra Pullmannová; Andrej Kováčik; Jarmila Zbytovská; Kateřina Vávrová
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

Review 6.  Nanodelivery Strategies for Skin Diseases with Barrier Impairment: Focusing on Ceramides and Glucocorticoids.

Authors:  Cíntia Almeida; Patrícia Filipe; Catarina Rosado; Catarina Pereira-Leite
Journal:  Nanomaterials (Basel)       Date:  2022-01-15       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.